ANI Pharma Inc (ANIP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 614,376 | 486,816 | 316,385 | 216,136 | 208,475 |
| Cost of Goods | 250,210 | 181,513 | 138,785 | 100,610 | 87,157 |
| Gross Profit | 364,166 | 305,303 | 177,600 | 115,526 | 121,318 |
| Operating Expenses | 363,792 | 258,845 | 213,668 | 155,929 | 137,491 |
| Operating Income | 584 | 46,971 | -35,283 | -39,793 | -16,016 |
| Interest Expense | 17,602 | 26,940 | 28,052 | 11,922 | 9,452 |
| Other Income | -5,194 | -159 | 670 | -4,343 | -494 |
| Pre-tax Income | -22,212 | 19,872 | -62,665 | -56,058 | -25,962 |
| Income Tax | -3,690 | 1,093 | -14,769 | -13,455 | -3,414 |
| Net Income Continuous | -18,522 | 18,779 | -47,896 | -42,603 | -22,548 |
| Net Income | $-18,522 | $18,779 | $-47,896 | $-42,603 | $-22,548 |
| EPS Basic Total Ops | -1.04 | 0.86 | -3.05 | -3.40 | -1.88 |
| EPS Basic Continuous Ops | -0.96 | 1.04 | -2.95 | -3.38 | -1.88 |
| EPS Diluted Total Ops | -1.04 | 0.85 | -3.05 | -3.40 | -1.88 |
| EPS Diluted Continuous Ops | -0.96 | 1.03 | -2.95 | -3.38 | -1.88 |
| EPS Diluted Before Non-Recurring Items | 4.01 | 3.85 | 0.68 | 2.58 | 2.87 |
| EBITDA(a) | $81,914 | $106,762 | $24,370 | $7,459 | $28,622 |